Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis

Study of fast-tracked and orphan designated alicaforsen is the largest ever in pouchitis, and aims to confirm efficacy in antibiotic refractory patients

Read full pressrelease here

 

 

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis

Kommentarer är avstängda.

Medical Need Europe AB

Medical Need is a privately held pharmaceutical company headquartered in Sweden, focusing on the provision of physical access to unlicensed medicines under international named patient regulations and the registration, distribution, marketing and sale of licensed orphan drugs and niche specialty pharmaceuticals across Europe, for the treatment of rare diseases where there is a high unmet medical need.
The company is currently active within several rare and niche disorders, such as; Urea Cycle Disorders, Niemann-Pick type C, Congenital-Sucrase-Isomaltase Deficiency, progressive multiple sclerosis (MS), hematological stem cell transplantation, brain tumors and Ménières disease.

Produced by 6ft5 & Krokedil.

Produced by 6ft5 & Krokedil.